JP2020073586A5 - - Google Patents

Download PDF

Info

Publication number
JP2020073586A5
JP2020073586A5 JP2020017875A JP2020017875A JP2020073586A5 JP 2020073586 A5 JP2020073586 A5 JP 2020073586A5 JP 2020017875 A JP2020017875 A JP 2020017875A JP 2020017875 A JP2020017875 A JP 2020017875A JP 2020073586 A5 JP2020073586 A5 JP 2020073586A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
biliary tract
tract cancer
agent according
dichloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020017875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020073586A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020073586A publication Critical patent/JP2020073586A/ja
Publication of JP2020073586A5 publication Critical patent/JP2020073586A5/ja
Priority to JP2023089646A priority Critical patent/JP7541400B2/ja
Pending legal-status Critical Current

Links

JP2020017875A 2017-12-28 2020-02-05 がん治療薬 Pending JP2020073586A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023089646A JP7541400B2 (ja) 2017-12-28 2023-05-31 がん治療薬

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017253385 2017-12-28
JP2017253385 2017-12-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019114783A Division JP6734971B2 (ja) 2017-12-28 2019-06-20 がん治療薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023089646A Division JP7541400B2 (ja) 2017-12-28 2023-05-31 がん治療薬

Publications (2)

Publication Number Publication Date
JP2020073586A JP2020073586A (ja) 2020-05-14
JP2020073586A5 true JP2020073586A5 (enExample) 2021-09-02

Family

ID=67066788

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019503591A Active JP6546367B1 (ja) 2017-12-28 2018-08-01 がん治療薬
JP2019114783A Active JP6734971B2 (ja) 2017-12-28 2019-06-20 がん治療薬
JP2020017875A Pending JP2020073586A (ja) 2017-12-28 2020-02-05 がん治療薬
JP2023089646A Active JP7541400B2 (ja) 2017-12-28 2023-05-31 がん治療薬

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019503591A Active JP6546367B1 (ja) 2017-12-28 2018-08-01 がん治療薬
JP2019114783A Active JP6734971B2 (ja) 2017-12-28 2019-06-20 がん治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023089646A Active JP7541400B2 (ja) 2017-12-28 2023-05-31 がん治療薬

Country Status (10)

Country Link
US (1) US12458628B2 (enExample)
EP (1) EP3733175B1 (enExample)
JP (4) JP6546367B1 (enExample)
KR (1) KR102377742B1 (enExample)
CN (1) CN111491632A (enExample)
BR (1) BR112020012766A2 (enExample)
CA (1) CA3083343C (enExample)
ES (1) ES2960392T3 (enExample)
MX (1) MX2020006678A (enExample)
WO (1) WO2019130637A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110945361B (zh) * 2017-11-07 2024-01-09 J制药股份有限公司 抗pd-1/pd-l1抗体疗法显效性的预测和提高方法以及评价癌症恶性程度的方法
EP3968785A4 (en) 2019-05-14 2023-01-11 Tyme, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
CN112336859A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 通过抑制t细胞摄取氨基酸治疗阿尔茨海默病的方法
CN115515575A (zh) * 2020-01-17 2022-12-23 迪美公司 用于调节癌症的酪氨酸衍生物
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections
JPWO2022102687A1 (enExample) * 2020-11-11 2022-05-19
KR20250145578A (ko) 2023-01-16 2025-10-13 제이 파마 가부시끼가이샤 담도암 치료제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008081537A1 (ja) * 2006-12-28 2008-07-10 Human Cell Systems, Inc. Lat1阻害活性を有する芳香族アミノ酸誘導体、それを含有するlat1阻害活性剤及びその製造方法
WO2015173970A1 (ja) * 2014-05-15 2015-11-19 ジェイファーマ株式会社 抗悪性腫瘍剤組成物
JP2017155023A (ja) 2016-03-04 2017-09-07 ジェイファーマ株式会社 Lat1阻害活性を有する芳香族アミノ酸誘導体を含有する注射剤
CN110945361B (zh) 2017-11-07 2024-01-09 J制药股份有限公司 抗pd-1/pd-l1抗体疗法显效性的预测和提高方法以及评价癌症恶性程度的方法
WO2021040043A1 (ja) 2019-08-30 2021-03-04 ジェイファーマ株式会社 特定の遺伝子マーカーを有する患者に用いる医薬組成物
JPWO2022102687A1 (enExample) 2020-11-11 2022-05-19

Similar Documents

Publication Publication Date Title
JP2010518122A5 (enExample)
JP2021063088A5 (enExample)
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
JP2010077141A5 (enExample)
JP2010512413A5 (enExample)
JP2012502015A5 (enExample)
JP2006523216A5 (enExample)
JP2022163049A5 (enExample)
CY1119886T1 (el) Μεθοδος βιομηχανικης κατασκευης μιας φαρμακευτικης συνθεσης στην μορφη δισκιων παρατεταμενης απελευθερωσης που περιεχουν πιρφενιδονη και χρηση αυτων στην υποστροφη χρονιας νεφρικης ανεπαρκειας, καψικης συσπασης μαστου και ηπατικης ινωσης σε ανθρωπους
CY1112499T1 (el) Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων
JP2004512318A (ja) C−ニトロソ化合物とその使用
JP2011529854A5 (enExample)
JP2007500154A5 (enExample)
JP2021152008A5 (enExample)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
JP2018531962A5 (enExample)
JP2019518022A5 (enExample)
JP2012533565A5 (enExample)
JP2021073257A5 (enExample)
JP2014521641A5 (enExample)
JP2017508817A5 (enExample)
JP2012512164A5 (enExample)
JP2019509253A5 (enExample)
JP2021509395A5 (enExample)
JP2010500284A5 (enExample)